Sweden’s Reference Pricing Proposal: A Five-Year Doomsday Clock For Innovation?
This article was originally published in The Pink Sheet Daily
Executive Summary
Sweden may link its existing value-based pricing system with international reference pricing to cut drug expenditure, a move the pharmaceuticals industry says would devastate domestic R&D there.